Australia’s Lung Cancer Screening Rollout Opens New Market for Medical AI, with Coreline Soft Gaining Ground
Australia’s national lung cancer screening program has passed 100,000 participants just over a year after its launch, giving medical imaging AI companies one of their clearest opportunities yet to prove their technology in a large-scale public screening program.Australia introduced the National Lung
Australia's national lung cancer screening program has reached 100,000 participants just over a year after its launch, presenting medical imaging AI companies with a prime opportunity to demonstrate their technology in a large-scale public screening initiative. Introduced in July 2025, the National Lung Cancer Screening Program (NLCSP) provides free low-dose CT scans to people aged 50 to 70 who are at high risk for developing lung cancer.
Since its inception, over 230 primary lung cancers have been detected through the program. One of the companies participating in the rollout is South Korea's Coreline Soft, which is supplying chest CT analysis software through a local partner. Coreline Soft's AI solution has been used in around 30,000 screening examinations, suggesting the company has already established a significant presence in the early stage of the program.
While this figure does not represent an official market share, it provides a valuable reference point for the company as it looks to expand its reach. Medical imaging AI companies have been focusing on accurately detecting lung nodules and other abnormalities, and national screening programs offer a unique opportunity to process large numbers of CT scans across multiple hospitals and imaging centers.
Coreline Soft's AVIEW platform is specifically designed for chest CT analysis and lung cancer screening, helping radiologists identify and measure pulmonary nodules and assess suspected lung cancer. The company has been concentrating on this area for years and now aims to increase its potential market share to as much as 70% of the screening market.
Coreline Soft is currently conducting trials with additional large healthcare institutions and looking to expand into public-sector providers. The Australian program also fits into the broader strategy that Coreline Soft has pursued in South Korea and Europe. As the program grows, it will provide Coreline Soft with a valuable reference point, demonstrating the practical aspects of maintaining its software as the screening program expands.
Written by urgent.news from Korea IT Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
